Quick Answer
BioScience Health Innovations, Inc. reported Net Income Loss of $642.1 thousand for the year ending 2025.
- BioScience Health Innovations, Inc. showed an increase of +638.0% in Net Income Loss from 2024 to 2025.
- This data is from BioScience Health Innovations, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: -$900.00 | Q4 2019: $0.00 | Q1 2020: -$1.9 thousand | Q2 2020: -$2.9 thousand | Q4 2020: -$5.6 thousand | Q1 2021: -$12.7 thousand | Q2 2021: -$3.2 thousand | Q4 2021: -$14.1 thousand | Q1 2022: -$17.5 thousand | Q1 2022: -$4.2 thousand | Q2 2022: -$47.9 thousand | Q2 2022: -$1.9 thousand | Q3 2022: -$84.7 thousand | Q4 2022: -$28.9 thousand | Q1 2023: -$20.0 thousand | Q1 2023: -$70.7 thousand | Q2 2023: -$85.3 thousand | Q3 2023: -$57.1 thousand | Q1 2024: -$53.4 thousand | Q2 2024: $74.2 thousand | Q3 2024: $56.2 thousand | Q1 2025: $426.8 thousand | Q2 2025: $457.7 thousand | Q3 2025: -$8.8 thousand.
- Over the full 7 years of available data (2020 to 2025), BioScience Health Innovations, Inc.'s Net Income Loss has grown by 8,458.4%.
- Historical annual values: Fiscal year 2025: $642.1 thousand | Fiscal year 2024: $87.0 thousand | Fiscal year 2023: -$251.5 thousand | Fiscal year 2022: -$170.5 thousand | Fiscal year 2022: -$83.2 thousand | Fiscal year 2021: -$25.6 thousand | Fiscal year 2020: -$7.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: